All Stories

  1. Direct oral anticoagulants vs vitamin K antagonist on dementia risk in atrial fibrillation: systematic review with meta-analysis
  2. Anticoagulação Oral e Incidência de Acidente Vascular Cerebral Associado a Fibrilhação Auricular em Portugal Continental: Um Estudo de Modelação
  3. Clinical Outcomes of Anticoagulated Patients With Atrial Fibrillation After Falls or Head Injury: Insights From RE-LY
  4. Expert perspectives on strategic factors for the management and prevention of heart failure in Portugal
  5. Prescrição de Benzodiazepinas e outros Sedativos na Administração Regional de Saúde de Lisboa e Vale do Tejo de 2013 a 2020: Um Estudo Retrospetivo
  6. Glossopharyngeal neuralgia with cardioinhibitory syncope: Is a permanent pacemaker required?
  7. Atrial fibrillation risk on Parkinson’s disease – a systematic review and meta-analysis
  8. Myocardial infarction and viral triggers: what do we know by now?
  9. Family history of premature myocardial infarction and the effect of aspirin
  10. Fish intake and risk of cardiovascular events: an analysis of the VITAL cohort
  11. Screening strategies for atrial fibrillation in the elderly population: a systematic review and network meta-analysis
  12. Cardiovascular and Respiratory Safety of Sedation Strategies Used in Transesophageal Echocardiography: A Systematic Review Incorporating Network Meta-Analysis
  13. The Accuracy of Hestia and Simplified PESI to Predict the Prognosis in Pulmonary Embolism: Systematic Review with Meta-analysis
  14. Clinical effects of off-label reduced doses of Direct Oral Anticoagulants: A systematic review and meta-analysis
  15. Systematic Review and Meta-analysis of Physician Modified Endografts for Treatment of Thoraco-Abdominal and Complex Abdominal Aortic Aneurysms
  16. The sham effect of invasive interventions in chronic coronary syndromes: a systematic review and meta-analysis
  17. The association of xanthelasma palpebrum with cardiovascular events: systematic review with meta-analysis
  18. Systematic reviews and meta-analysis published in indexed Portuguese medical journals: time trends and critical appraisal
  19. High sensitivity troponins: From the acute setting to the general population
  20. Does autosomal dominant polycystic kidney disease increase the risk of aortic aneurysm or dissection: a point of view based on a systematic review and meta-analysis
  21. Low risk of haematomas with intramuscular vaccines in anticoagulated patients: a systematic review with meta-analysis
  22. Incidence of acute aortic dissections in patients with out of hospital cardiac arrest: A systematic review and meta-analysis of observational studies
  23. Anticoagulation therapy in patients with post-operative atrial fibrillation: Systematic review with meta-analysis
  24. A systematic review and meta-analysis of the incidence of acute aortic dissections in population-based studies
  25. Incidence and Prevalence of Thoracic Aortic Aneurysms: A Systematic Review and Meta-analysis of Population-Based Studies
  26. The high-risk bleeding category of different scores in patients with venous thromboembolism: Systematic review and meta-analysis
  27. COVID-19 and myocardial infarction
  28. Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity
  29. Risk of SARS‐CoV‐2 Infection and COVID‐19 Severity Associated With Exposure to Nonsteroidal Anti‐Inflammatory Drugs: Systematic Review and Meta‐Analysis
  30. Anticoagulation after typical atrial flutter ablation: Systematic review and meta‐analysis
  31. Low-Dose Colchicine in Coronary Artery Disease ― Systematic Review and Meta-Analysis ―
  32. Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis
  33. The impact of influenza vaccination in patients with cardiovascular disease: An overview of systematic reviews
  34. The Impact of Different Types of Shift Work on Blood Pressure and Hypertension: A Systematic Review and Meta-Analysis
  35. Cardiovascular and cerebrovascular risk markers in Parkinson’s disease: Results from a case−control study
  36. Atherosclerosis: The cost of illness in Portugal
  37. Does Parkinson's Disease Increase the Risk of Atrial Fibrillation? Insights From Electrocardiogram and Risk Scores From a Case-Control Study
  38. Cochrane Corner: Withdrawal of antihypertensive drugs in older people
  39. Cochrane Corner: Withdrawal of antihypertensive drugs in older people
  40. Doxycycline is not Effective in Reducing Abdominal Aortic Aneurysm Growth: A Mini Systematic Review and Meta-Analysis of Randomised Controlled Trials
  41. Antithrombotic Therapy Recommendations in the European Society of Cardiology Guidelines: How Robust Are the Randomized Controlled Trials Underpinning Them?
  42. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe
  43. Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 infection severity
  44. Soluble CD40 ligand expression in stable atherosclerosis: A systematic review and meta-analysis
  45. The Risk of Mortality Associated With Opioid Use in Patients With Acute Heart Failure: Systematic Review and Meta-analysis
  46. Safety and tolerability of sacubitril-valsartan: a systematic review and meta-analysis
  47. Fluoroquinolones Are Associated With Increased Risk of Aortic Aneurysm or Dissection: Systematic Review and Meta-analysis
  48. The Prognostic Value of Exercise Echocardiography After Percutaneous Coronary Intervention
  49. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: Systematic review and meta-analysis
  50. The incidence of thrombotic events with idarucizumab and andexanet alfa: A systematic review and meta-analysis
  51. Opioids prescribing trend between 2013 and 2017 in the Lisbon and Tagus Valley region, Portugal
  52. Satisfaction of Patients with Nonvitamin K Anticoagulants Compared to Vitamin K Antagonists: a Systematic Review and Meta-analysis
  53. Synchronous and Metachronous Thoracic Aortic Aneurysms in Patients With Abdominal Aortic Aneurysms: A Systematic Review and Meta‐Analysis
  54. Reminder: Cardiovascular Patients Also Benefit from Influenza Vaccine
  55. Safety of coffee consumption after myocardial infarction: A systematic review and meta-analysis
  56. Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment
  57. Aspirin for Primary Cardiovascular Prevention in Patients with Family History of Cardiovascular Disease: Meta-analysis
  58. Effect of oxygen supply on mortality in acute ST-elevation myocardial infarction: systematic review and meta-analysis
  59. N‐Terminal Pro‐B‐Type Natriuretic Peptide Levels in Parkinson's Disease
  60. Radiofrequency catheter ablation of ventricular tachycardia in ischemic heart disease in light of current practice: a systematic review and meta-analysis of randomized controlled trials
  61. The burden of atherosclerosis in Portugal
  62. Multimodality imaging in the recurrence of left ventricular pseudoaneurysm after surgical correction
  63. The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis
  64. Alterações Eletrocardiográficas Induzidas pela Hipotermia
  65. Aspirin in the primary prevention of cardiovascular disease on diabetic patients: Systematic review and meta-analysis
  66. Once- versus Twice-Daily Aspirin in Patients at High Risk of Thrombotic Events: Systematic Review and Meta-Analysis
  67. Reply to the letter ‘We never speak about sudden unexpected death in Parkinson’s disease’
  68. Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: systematic review and meta-analysis
  69. Cardiovascular Adverse Events Reported in Placebo Arm of Randomized Controlled Trials in Parkinson’s Disease
  70. Cardiovascular events reported in randomized controlled trials in restless legs syndrome
  71. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review
  72. Reporting and methodological quality of clinical trials on exercise therapy for Parkinson's disease
  73. Reply to letter: Does Parkinson’s disease increase the risk of cardiovascular events? A systematic review and meta‐analysis
  74. Physical Activity, Exercise, and Physiotherapy in Parkinson's Disease: Defining the Concepts
  75. The association of Influenza infection and vaccine with myocardial infarction: systematic review and meta-analysis of self-controlled case series.
  76. Adjuvant antithrombotic therapy in ST-elevation myocardial infarction: Contemporaneous Portuguese cross-sectional data
  77. Recommendations and levels of evidence in the guidelines of the European Society of Cardiology: current scenario and time trends
  78. Cochrane Corner: Perioperative beta-blockers for preventing surgery-related mortality and morbidity
  79. Does Parkinson's disease increase the risk of cardiovascular events? A systematic review and meta‐analysis
  80. Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies
  81. Corrigendum to “Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis” [Arch. Gerontol. Geriatr. 81 (March–April) (2019) 209–214]
  82. Adjuvant antithrombotic therapy in ST-elevation myocardial infarction: A narrative review
  83. Morphine in acute coronary syndrome: systematic review and meta-analysis
  84. Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis
  85. Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysis
  86. The current and future burden of heart failure in Portugal
  87. Fatores de Risco para Mortalidade Hospitalar na Endocardite Infecciosa
  88. Non-vitamin K antagonist oral anticoagulants (NOACs) in cardioversions: The past, the present and the future
  89. Deprescribing cardiovascular drugs in low-risk patients increases the risk of uncontrolled blood pressure and LDL-cholesterol
  90. Non-vitamin K antagonist oral anticoagulants and infective endocarditis
  91. Factors influencing patient delay before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: The Stent for life initiative in Portugal
  92. Thrombus aspiration in patients with ST-elevation myocardial infarction: results of a national registry of interventional cardiology
  93. Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study
  94. Novel Antithrombotic Drugs and Intraocular Bleeding
  95. Influenza vaccination and prevention of cardiovascular disease mortality
  96. Adoção da estratégia invasiva precoce no enfarte agudo do miocárdio sem supra desnivelamento de ST: análise dos resultados do Registo Nacional de Síndromas Coronárias Agudas
  97. The value of Time in Therapeutic Range in the prediction of outcomes at a populational level in patients treated with vitamin K antagonists
  98. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis
  99. Caffeine does not increase the arrhythmic burden in patients with heart failure and left ventricular systolic dysfunction
  100. Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis
  101. A era dos novos anticoagulantes orais em Portugal
  102. Accuracy of diagnostic tests for Legionnaires' disease: a systematic review
  103. Bioengineered Temporomandibular Joint Disk Implants: Study Protocol for a Two-Phase Exploratory Randomized Preclinical Pilot Trial in 18 Black Merino Sheep (TEMPOJIMS)
  104. Thromboprophylaxis With Apixaban in Patients Undergoing Major Orthopedic Surgery: Meta-Analysis and Trial-Sequential Analysis
  105. Are there effective interventions to prevent hospital-acquired Legionnaires' disease or to reduce environmental reservoirs of Legionella in hospitals? A systematic review
  106. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis
  107. Safety of non-vitamin K antagonist oral anticoagulants - coronary risks
  108. Cochrane Corner: uso do balão intra‐aórtico em doentes com enfarte agudo do miocárdio complicado com choque cardiogénico
  109. Bridging Anticoagulation in Patients with Atrial Fibrillation
  110. Complicações de enfarte do miocárdio: ecocardiograma para diagnóstico diferencial de sopro cardíaco
  111. Custo‐efetividade dos novos anticoagulantes orais na fibrilhação auricular em Portugal
  112. Is the time in therapeutic range using the ratio of tests equivalent to the Rosendaal method?
  113. Cochrane Corner: colchicina na pericardite aguda e recorrente
  114. Glaucoma Surgery and Anticoagulant Therapy—Reply
  115. Systematic review with meta-analysis: the risk of major gastrointestinal bleeding with non-vitamin K antagonist oral anticoagulants
  116. Risk of Substantial Intraocular Bleeding With Novel Oral Anticoagulants
  117. Tolerability and Acceptability of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-Analysis
  118. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis
  119. Risk of renal failure with the non-vitamin K antagonist oral anticoagulants: systematic review and meta-analysis
  120. Left ventricular thrombus in repaired Tetralogy of Fallot
  121. Pericardial bleeding risk with non-vitamin K oral anticoagulants: A meta-analysis
  122. Takotsubo cardiomyopathy, beyond ventriculography and classical bidimensional echocardiography
  123. Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis
  124. Risk of insomnia with non-vitamin K oral anticoagulants: systematic review and meta-analysis
  125. How safe is acetaminophen use in patients treated with vitamin K antagonists? A systematic review and meta-analysis
  126. Carga e custo da fibrilhação auricular em Portugal
  127. Cochrane Corner – administração de corticosteroides para miocardite de etiologia viral
  128. The burnout stage of an apical hypertrophic cardiomyopathy
  129. Thromboembolic risk in the initiation, switch and interruption/re-initiation of oral anticoagulants: Do newcomers improve outcomes? Insights from a meta-analysis of RCTs
  130. Cochrane Corner: Qual é o impacto clínico da administração de oxigénio em doentes com enfarte agudo do miocárdio? Avaliação de uma revisão sistemática Cochrane
  131. Controlled pericardiocentesis in patients with cardiac tamponade complicating aortic dissection: Experience of a centre without cardiothoracic surgery
  132. Prevalência da anticoagulação oral em doentes com fibrilhação auricular em Portugal: revisão sistemática e meta‐análise de estudos observacionais
  133. Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis
  134. Oral Anticoagulation for Pulmonary Arterial Hypertension: Systematic Review and Meta-analysis
  135. Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: a systematic review and meta-analysis
  136. Impacto da frequência posológica na adesão terapêutica em doenças cardiovasculares crónicas: revisão sistemática e meta‐análise
  137. Net clinical benefit outcome should be standardized in trials evaluating antithrombotic drugs: The example of NOACs in atrial fibrillation
  138. Efficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta‐analysis
  139. Dyspnea and Reversibility Profile of P2Y12 Antagonists: Systematic Review of New Antiplatelet Drugs
  140. The risk of infection with new oral anticoagulants: A meta-analysis
  141. Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis
  142. Evaluation of time in therapeutic range in anticoagulated patients: a single-center, retrospective, observational study
  143. Cochrane corner - Antiagregantes plaquetários na doença renal crónica. Avaliação da revisão sistemática
  144. Warfarin, acetylsalicylic acid and risk of incident atrial fibrillation in patients with heart failure and sinus rhythm: A meta-analysis
  145. Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies
  146. Infliximab Reduces Hospitalizations and Surgery Interventions in Patients With Inflammatory Bowel Disease
  147. Clinical applications of exercise stress echocardiography in the treadmill with upright evaluation during and after exercise
  148. Um caso de tromboembolismo pulmonar e dissecção aórtica: importância do ecocardiograma
  149. Branded Versus Generic Clopidogrel in Cardiovascular Diseases
  150. Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors
  151. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis
  152. Rate versus rhythm control in atrial fibrillation and clinical outcomes: Updated systematic review and meta-analysis of randomized controlled trials
  153. Rate vs rhythm control in patients with atrial fibrillation and heart failure: A systematic review and meta-analysis of randomised controlled trials
  154. Educational Strategies to Reduce Serum Phosphorus in Hyperphosphatemic Patients With Chronic Kidney Disease: Systematic Review With Meta-analysis
  155. Skin antiseptics in venous puncture-site disinfection for prevention of blood culture contamination: systematic review with meta-analysis
  156. Deep Purple Urine